Voorbeelden van het gebruik van Tablet formulation in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Epivir is also available as a tablet formulation.
The tablet formulation is not adapted for use in infants
Ziagen is also available as a tablet formulation.
Epivir is also available as a tablet formulation for patients who weigh at least 14 kg see section 4.4.
No data are available for the tablet formulation.
A 19% increase in the Cmax of the tablet formulation(CABOMETYX) compared to the capsule formulation(COMETRIQ) was observed.
The absolute bioavailability of the tablet formulation is 67.
The tablet formulation was investigated in AML and MDS patients
Whenever possible in children, Epivir as tablet formulation should preferably be used.
Therefore, the efficacy of Aerius orodispersible tablet is expected to be the same as with the Aerius tablet formulation.
Absolute bioavailability of the febuxostat tablet formulation has not been studied.
Enurace 50 is a tablet formulation containing ephedrine as active ingredient
Patients can be switched from the solution to the tablet formulation on a mg per mg basis.
also spend a tablet formulation in vain.
In a multiple-dose pharmacokinetic study conducted with the tablet formulation in healthy adult subjects, four subjects were
At the recommended dose, Aerius 5 mg orodispersible tablet was found to be bioequivalent to the Aerius 5 mg conventional tablet formulation of desloratadine.
Reduction of daily dose by 7 mg/kg/day(film-coated tablet formulation), if following renal parameters are observed at two consecutive visits
after which all patients were administered the tablet formulation once daily
As an accurate dosage cannot be achieved with the 300 mg non- scored tablet formulation in this patient population, it is recommended that the Epivir 150 mg scored
In a pharmacokinetic crossover study(AC-052-116), 16 healthy adult subjects received 62.5 mg bosentan using the 62.5 mg film-coated tablet formulation or 64 mg bosentan using the 32 mg dispersible tablet formulation.
Modified Release Tablets Formulation Regarding the modified release tablet SPC, no proposal for a harmonised SPC was provided.
The effect of meal content on nelfinavir exposure was investigated in a study using the 250 mg film-coated tablets formulation.